Healthcare Marijuana, Inc. Subsidiary Kannaway® Starts Recruiting CBD Customers for ValidCare Virtual Study(TM)

green grass

SAN DIEGO, Sept. 02, 2020 (GLOBE NEWSWIRE) — by means of NEWMEDIAWIRE — Healthcare Marijuana, Inc. (OTC: MJNA) (the “Business”), the initially-ever publicly traded cannabis enterprise in the United States that launched the world’s initially-ever cannabis-derived nutraceutical items, brands and provide chain, announced currently that its subsidiary Kannaway® has begun recruiting cannabidiol (CBD) customers to participate in the ValidCare CBD security study. The nationwide observational study is utilizing its items to measure the possible effects on the liver of orally consumed, hemp-derived CBD items in healthier adults. Participants will supply actual-time feedback by means of ValidCare’s Virtual Study&#x2122 platform and provide blood samples for evaluation as component of the study.

“Since day one particular, we have been devoted to giving our shoppers with secure, constant items they can trust,” stated Healthcare Marijuana, Inc. CEO Dr. Stuart Titus. “This study assists us additional that commitment and lets us take component in an business work to supply additional proof that CBD holds lots of wellness added benefits with no dangerous side effects.”

The IRB-authorized study, which was made to respond to the FDA’s lots of requests for science-primarily based information, is becoming carried out by ValidCare and qualifies as a national clinical trial. Kannaway® is one particular of 13 business-major organizations to participate and assistance the FDA establish the regulatory path for hemp-derived CBD items. Every single enterprise is accountable for giving lot-certain item information and facts for the study and recruiting a target of one hundred shoppers to participate. Upon completion of the study, Kannaway will acquire security information pertaining to these certain participants. Customers are screened to guarantee they meet study criteria prior to they are authorized and enrolled. Participants will use Kannaway hemp-derived CBD or CBD isolate items for 30 consecutive days and supply a blood sample. More than 1,000 shoppers have expressed interest in becoming component of the study.

“It’s encouraging to see the CBD business operating collectively to additional CBD study,” stated Kannaway® CEO Blake Schroeder. “We invest significantly in scientific study, like internal and external independent research such as ValidCare’s mainly because it is critical to gaining customer trust.”

Benefits of the study will be shared with the FDA and are anticipated to be published in a peer-reviewed journal in early 2021.

To understand much more about the study please go to https://validcare.com/validcare-national-cbd-liver-function-study/.

About ValidCare

ValidCare, LLC supplies contract study outsourcing (CRO) and virtual study options for life sciences and customer packaged goods industries. ValidCare’s proprietary platform supports decentralized, hybrid and virtual study powered by actual globe proof (RWE) to provide insights that assistance fuel healthier generations. For much more information and facts, go to www.validcare.com or get in touch with 844-825-4322.

About Kannaway
Kannaway® is a network sales and marketing and advertising enterprise specializing in the sales and marketing and advertising of hemp-primarily based botanical items. Kannaway® presently hosts weekly on the web sales meetings and conferences across the United States, supplying exceptional insight and chance to sales pros who are desirous of becoming prosperous leaders in the sale and marketing and advertising of hemp-primarily based botanical items.

About Healthcare Marijuana, Inc.
We are a enterprise of firsts®. Healthcare Marijuana, Inc. (MJNA) is a cannabis enterprise with 3 distinct enterprise units in the non-psychoactive cannabinoid space: a international portfolio of cannabinoid-primarily based nutraceutical brands led by Kannaway® and HempMeds® a pioneer in sourcing the highest-excellent legal non-psychoactive cannabis items derived from industrial hemp and a cannabinoid-primarily based clinical study and botanical drug improvement sector led by its pharmaceutical investment organizations and partners like AXIM® Biotechnologies, Inc. and Kannalife, Inc. Healthcare Marijuana, Inc. was named a major CBD producer by CNBC. Healthcare Marijuana, Inc. was also the initially enterprise to acquire historic import permits for CBD items from the governments of Brazil, Mexico, Argentina, and Paraguay and is a leader in the improvement of international markets. The company’s flagship item Actual Scientific Hemp Oil has been employed in quite a few prosperous clinical research all through Mexico and Brazil to comprehend its security and efficacy.

Healthcare Marijuana, Inc.’s headquarters is in San Diego, California, and further information and facts is readily available at OTCMarkets.com or by going to www.medicalmarijuanainc.com. To see Healthcare Marijuana, Inc.’s corporate video, click right here.

Shareholders and shoppers are also encouraged to obtain CBD oil and other items at Healthcare Marijuana, Inc.’s shop.

FORWARD-Searching DISCLAIMER
This press release may possibly include particular forward-hunting statements and information and facts, as defined inside the which means of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is topic to the Secure Harbor designed by these sections. This material includes statements about anticipated future events and/or economic benefits that are forward-hunting in nature and topic to dangers and uncertainties. Such forward-hunting statements by definition involve dangers, uncertainties and other variables, which may possibly bring about the actual benefits, overall performance or achievements of Healthcare Marijuana, Inc. to be materially various from the statements produced herein.

Meals AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the Meals and Drug Administration. This item is not intended to diagnose, treat, remedy, or stop any illness.

LEGAL DISCLOSURE
Healthcare Marijuana, Inc. does not sell or distribute any items that are in violation of the United States Controlled Substances Act.

Make contact with:

Public Relations Make contact with:
Andrew Difficult
Chief Executive Officer
CMW Media
P. 858-264-6600
[email protected]
www.cmwmedia.com

Investor Relations Make contact with:
P. (858) 283-4016
[email protected]

Primary Logo

If You Liked This Post Click To Share

.mobile_tx{show: none}
#ax1x{
font-size: 1.1em
font-weight: bold
line-height: 1.five
clear:each
margin: 0px 0px 20px 1% !essential
min-height: four.5em
text-transform: uppercase
padding: .25em 10px
position: relative
width: 98%
float: left
}
.subsequent-pg {
height: 85px !essential
width: one hundred%
border-major-left-radius: 3px
border-bottom-left-radius: 3px
background-colour: #e5192c
background-image: url(‘/wp-content material/themes/mh-magazine/pictures/international-following.png’) !essential
background-repeat: no-repeat
background-position: ideal center
background-size: auto one hundred%
overflow: hidden
box-sizing: border-box
margin-bottom: 0px
margin-major: 10px
position: relative
padding-left: 100px
}
.subsequent-pg::prior to {
width: 45px !essential
height: 85px !essential
show: block
content material: “”
width: 32px
height: 64px
background-image: url(‘/wp-content material/themes/mh-magazine/pictures/international-prior to.png’) !essential
background-repeat: no-repeat
background-position: ideal center
background-size: auto one hundred%
position: absolute
left: -4px
major: 0px
}
.action-txt {
text-transform: uppercase
margin: 12px
line-height: 61px
text-align: left
font-size: 36px
background-repeat: no-repeat
background-position: ideal center
background-size: 26px 18px
colour: #FFF
float: left
font-weight: bold
font-household: “Open Sans”,sans-serif !essential
width: 78%
show: inline-block
text-align: center
}
@media (max-width: 768px){
.mobile_tx{show: block}
.desktop_tx{show: none}
.pps-slider-nav .pps-subsequent {
text-align: center
position: static
padding: 5px 20px
float: left
width: one hundred%
box-sizing: border-box
}
.pps-subsequent .subsequent-report-web page {
padding-left:
float: left
margin:
}
.subsequent-report-web page .action-txt {
padding-left: !essential
text-align: center
width: 87%
box-sizing: border-box
font-size: 26px
background:
text-align: center
}
#ax1x {
padding: .25em !essential
min-height: two.3em
width: one hundred% !essential
margin: 0px !essential
margin-bottom: 15px !essential
padding-bottom: !essential
}
}
@media (max-width: 500px){
.subsequent-report-web page .action-txt{
width: 75%
}
}

Latest posts